HOME >> MEDICINE >> NEWS
Women need not wait to conceive after breast cancer

Young women who are diagnosed with breast cancer need not wait the recommended two years after treatment before attempting to conceive, says a study published on bmj.com today.

Women of childbearing age who are diagnosed with breast cancer are currently advised to wait at least two years after treatment to become pregnant. This is mainly to identify those who relapse early and have a poor prognosis, but there are no published data to suggest that postponing conception will affect the outcome of the cancer or pregnancy. In fact, some studies have implied that subsequent pregnancy may provide a survival benefit.

So researchers in Western Australia set out to investigate the effects of pregnancy after breast cancer.

They identified 123 women aged 15-44 who were diagnosed with breast cancer and had at least one pregnancy after their diagnosis. The average age at first subsequent pregnancy was 35.

Sixty two (50%) women conceived within two years of their diagnosis (29 of them had an abortion, 27 had a live birth, and six miscarried). More abortions occurred in the first six months after breast cancer was diagnosed and while the woman was undergoing active treatment.

Women who became pregnant had improved overall survival compared with those who didnt. This protective effect was seen for women who waited at least six months to become pregnant, but it was stronger (statistically significant) among women who waited two years after treatment.

This study does not support the current medical advice given to premenopausal women diagnosed with breast cancer to wait two years before attempting to conceive, say the authors.

This recommendation may be valid for women who are receiving treatment or have systemic disease at diagnosis, but for women with localised disease, early conception after completion of their treatment is unlikely to adversely affect their survival, they conclu
'"/>

Contact: Emma Dickinson
edickinson@bmj.com
44-020-738-36529
BMJ-British Medical Journal
7-Dec-2006


Page: 1 2

Related medicine news :

1. Women with migraines and visual symptoms may have higher stroke risk
2. Womens mortality rates for cardiovascular disease differ widely among hospitals
3. Women with breast cancer do not get potentially life-saving information, survey reveals
4. New health insurance survey -- Women have trouble affording care needed
5. Women without regular medical care at increased risk of ovarian cancer
6. Women need expanded musculoskeletal care during pregnancy, study finds
7. NHLBI awards 12 Womens Health Initiative contracts
8. Women on osteoporosis drug can discontinue use with no risk
9. Women with rheumatoid arthritis have significantly less chance of remission than men
10. Women with mental disorders less likely to have mammograms
11. Alarming revelation: Women over 50 live in fear

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Women need not wait conceive after breast cancer

(Date:5/22/2013)... 2013, Paris, France: Results from a large ... question whether bivalirudin is superior to heparin ... similar 30-day mortality in patients with non-ST ... percutaneous coronary intervention (PCI)., European and US ... an alternative to unfractionated heparin plus GP ...
(Date:5/22/2013)... In the past decade, more than 500,000 ... with donated uniforms, shoes, balls and other equipment, thanks ... with manufacturers to provide youth with sporting goods. Now, ... in sports and fitness equipment over 10 years, as ... physical activity. , An inaugural donation of 500 ...
(Date:5/22/2013)... Kincardine, Ontario, CA (PRWEB) May 22, 2013 ... Meltdown Challenge, the fitness franchise Fit Body ... its 2nd Annual 1,000 lb. Meltdown Challenge starting on ... located at Davidson Centre 601 Durham Street, Kincardine, Ontario.     ... goal is to inspire and motivate local community residents ...
(Date:5/22/2013)... May 22, 2013 AvePoint ... solutions for social enterprise collaboration platforms, today announced ... firm based in Chicago, Ill. The agreement will ... and provide best-in-class solutions for SharePoint deployments, enabling ... , AvePoint’s DocAve Software Platform and ...
(Date:5/22/2013)... (PRWEB) May 22, 2013 Poor adherence ... in not only medical complications and death (some 125,000 ... drug non-adherence), but increased health-care costs. It’s been estimated ... admissions are related to poor medication adherence — a ... billion annually. , Indeed, so dire is the degree ...
Breaking Medicine News(10 mins):Health News:Registry questions superiority of bivalirudin over heparin 2Health News:Good Sports celebrates 10-year anniversary with major milestone: 500,000 American kids equipped for physical activity 2Health News:Good Sports celebrates 10-year anniversary with major milestone: 500,000 American kids equipped for physical activity 3Health News:Kincardine Fitness Center Promotes 2nd Annual 1,000 lb. Meltdown Challenge to Fight Obesity With All Proceeds Raised Going to Local Charity 2Health News:Kincardine Fitness Center Promotes 2nd Annual 1,000 lb. Meltdown Challenge to Fight Obesity With All Proceeds Raised Going to Local Charity 3Health News:AvePoint Teams with Tahoe Partners, LLC to Enrich Microsoft SharePoint Deployments and Improve Collaboration 2Health News:AvePoint Teams with Tahoe Partners, LLC to Enrich Microsoft SharePoint Deployments and Improve Collaboration 3Health News:Patient Prompt® Announces New Drug Adherence Program to Assist in Prescribed Medication Compliance 2
(Date:5/21/2013)... Massachusetts , 21. Mai 2013 /PRNewswire/ ... („OSI"), die die Firmen OMNIlife science® Inc., Enztec ... zählt, hat zwei neue, erfahrene Mitglieder in ... , eine erfahrene Führungspersönlichkeit aus der ... David Johnson , anerkannter ...
(Date:5/21/2013)... May 21, 2013  LCA-Vision Inc. (NASDAQ: LCAV ... the Lasik Plus ® brand, announces that all nominees to ... at today,s annual meeting of stockholders.  These Directors are: ... President of Bahl & Gaynor Investment Counsel , ... , Edgar F. Heizer III , ...
(Date:5/21/2013)... 21, 2013  Decision Resources, one of ... for pharmaceutical and healthcare issues, finds that ... key efficacy endpoints, including overall survival and ... influence over surveyed U.S. and European oncologists, ... HER2-negative breast cancer. The two novel emerging ...
Breaking Medicine Technology:Orthopaedic Synergy Inc. meldet bedeutenden Zuwachs im Vorstand 2Orthopaedic Synergy Inc. meldet bedeutenden Zuwachs im Vorstand 3LCA-Vision Reports on Annual Meeting of Stockholders 2LCA-Vision Reports on Annual Meeting of Stockholders 3LCA-Vision Reports on Annual Meeting of Stockholders 4Thought-Leader Opinion and Clinical Data Indicate that Emerging Agents from Two Drug Classes Have Efficacy Advantages Over Currently Used Therapies for HR-Positive, HER2-Negative Breast Cancer 2
Cached News: